{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:09:57Z","timestamp":1777478997771,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/npp.2015.24","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T11:54:11Z","timestamp":1422014051000},"page":"1762-1771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["R-Modafinil Attenuates Nicotine-Taking and Nicotine-Seeking Behavior in Alcohol-Preferring Rats"],"prefix":"10.1038","volume":"40","author":[{"given":"Xiao-Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Tao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluyomi M","family":"Okunola-Bakare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel D","family":"Slack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliot L","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"BFnpp201524_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","volume":"120","author":"AL Anderson","year":"2012","unstructured":"Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E et al (2012). Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend 120: 135\u2013141.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201524_CR2","first-page":"CD006103","volume":"4","author":"K Cahill","year":"2007","unstructured":"Cahill K, Stead LF, Lancaster T (2007). Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 4: CD006103.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFnpp201524_CR3","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1176\/appi.ajp.159.11.1947-a","volume":"159","author":"A Camacho","year":"2002","unstructured":"Camacho A, Stein MB (2002). Modafinil for social phobia and amphetamine dependence. Am J Psychiatry 159: 1947\u20131948.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201524_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1021\/ml1002025","volume":"2","author":"J Cao","year":"2010","unstructured":"Cao J, Prisinzano TE, Okunola OM, Kopajtic T, Shook M, Katz JL et al (2010). Structure-activity relationships at the monoamine transporters for a novel series of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) analogues. ACS Med Chem Lett 2: 48\u201352.","journal-title":"ACS Med Chem Lett"},{"key":"BFnpp201524_CR5","first-page":"85","volume":"7","author":"KV Carson","year":"2013","unstructured":"Carson KV, Brinn MP, Robertson TA, To ANR, Esterman AJ, Peters M et al (2013). Current and emerging pharmacotherapeutic options for smoking cessation. Subst Abuse 7: 85\u2013105.","journal-title":"Subst Abuse"},{"key":"BFnpp201524_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.npp.1300600","volume":"30","author":"CA Dackis","year":"2005","unstructured":"Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30: 205\u2013211.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201524_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","volume":"43","author":"CA Dackis","year":"2012","unstructured":"Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T et al (2012). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat 43: 303\u2013312.","journal-title":"J Subst Abuse Treat"},{"key":"BFnpp201524_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","volume":"70","author":"CA Dackis","year":"2003","unstructured":"Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW et al (2003). Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70: 29\u201337.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201524_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.drugalcdep.2009.08.013","volume":"106","author":"R De La Garza 2nd","year":"2010","unstructured":"De La Garza R 2nd, Zorick T, London ED, Newton TF (2010). Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend 106: 173\u2013180.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201524_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00213-002-1080-8","volume":"161","author":"V Deroche-Gamonet","year":"2002","unstructured":"Deroche-Gamonet V, Darnaudery M, Bruins-Slot L, Piat F, Le Moal M, Piazza PV (2002). Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology 161: 387\u2013395.","journal-title":"Psychopharmacology"},{"key":"BFnpp201524_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fpsyt.2011.00064","volume":"2","author":"M Diana","year":"2011","unstructured":"Diana M (2011). The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry 2: 64.","journal-title":"Front Psychiatry"},{"key":"BFnpp201524_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1185\/030079906X80378","volume":"22","author":"DF Dinges","year":"2006","unstructured":"Dinges DF, Arora S, Darwish M, Niebler GE (2006). Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Curr Med Res Opin 22: 159\u2013167.","journal-title":"Curr Med Res Opin"},{"key":"BFnpp201524_CR13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3565(24)37050-8","volume":"283","author":"DM Edgar","year":"1997","unstructured":"Edgar DM, Seidel WF (1997). Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther 283: 757\u2013769.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201524_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2165\/11203290-000000000-00000","volume":"23","author":"KP Garnock-Jones","year":"2009","unstructured":"Garnock-Jones KP, Dhillon S, Scott LJ (2009). Armodafinil. CNS Drugs 23: 793\u2013803.","journal-title":"CNS Drugs"},{"key":"BFnpp201524_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/BF02247379","volume":"126","author":"LH Gold","year":"1996","unstructured":"Gold LH, Balster RL (1996). Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology 126: 286\u2013292.","journal-title":"Psychopharmacology"},{"key":"BFnpp201524_CR16","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.addbeh.2012.04.006","volume":"38","author":"AE Goudriaan","year":"2013","unstructured":"Goudriaan AE, Veltman DJ, van den Brink W, Dom G, Schmaal L (2013). Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI. Addict Behav 38: 1509\u20131517.","journal-title":"Addict Behav"},{"key":"BFnpp201524_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.npp.1301472","volume":"33","author":"CL Hart","year":"2008","unstructured":"Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW (2008). Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33: 761\u2013768.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201524_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.drugalcdep.2011.07.010","volume":"120","author":"NA Holtz","year":"2012","unstructured":"Holtz NA, Lozama A, Prisinzano TE, Carroll ME (2012). Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone. Drug Alcohol Depend 120: 233\u2013237.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201524_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/14622200701365293","volume":"9","author":"JR Hughes","year":"2007","unstructured":"Hughes JR, Callas PW, Peters EN (2007). Interest in gradual cessation. Nicotine Tob Res 9: 671\u2013675.","journal-title":"Nicotine Tob Res"},{"key":"BFnpp201524_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00002826-200005000-00004","volume":"23","author":"DR Jasinski","year":"2000","unstructured":"Jasinski DR, Kovacevic-Ristanovic R (2000). Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol 23: 149\u2013156.","journal-title":"Clin Neuropharmacol"},{"key":"BFnpp201524_CR21","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1523\/JNEUROSCI.4895-05.2006","volume":"26","author":"AD Le","year":"2006","unstructured":"Le AD, Li Z, Funk D, Shram M, Li TK, Shaham Y (2006). Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake. J Neurosci 26: 1872\u20131879.","journal-title":"J Neurosci"},{"key":"BFnpp201524_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1465-3362.2012.00473.x","volume":"32","author":"N Lee","year":"2013","unstructured":"Lee N, Pennay A, Hester R, McKetin R, Nielsen S, Ferris J (2013). A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes. Drug Alcohol Rev 32: 88\u201395.","journal-title":"Drug Alcohol Rev"},{"key":"BFnpp201524_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","volume":"72","author":"CJ Loland","year":"2012","unstructured":"Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S et al (2012). R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biol Psychiatry 72: 405\u2013413.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201524_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1369-1600.2012.00506.x","volume":"19","author":"SV Mahler","year":"2014","unstructured":"Mahler SV, Hensley-Simon M, Tahsili-Fahadan P, Lalumiere RT, Thomas C, Fallon RV et al (2014). Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors. Addict Biol 19: 49\u201360.","journal-title":"Addict Biol"},{"key":"BFnpp201524_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/00952990600920425","volume":"32","author":"R Malcolm","year":"2006","unstructured":"Malcolm R, Swayngim K, Donovan JL, DeVane CL, Elkashef A, Chiang N et al (2006). Modafinil and cocaine interactions. Am J Drug Alcohol Abuse 32: 577\u2013587.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BFnpp201524_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.conb.2013.01.003","volume":"23","author":"NJ Marchant","year":"2013","unstructured":"Marchant NJ, Li X, Shaham Y (2013). Recent developments in animal models of drug relapse. Curr Opin Neurobiol 23: 675\u2013683.","journal-title":"Curr Opin Neurobiol"},{"key":"BFnpp201524_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jsat.2007.12.003","volume":"35","author":"C McGregor","year":"2008","unstructured":"McGregor C, Srisurapanont M, Mitchell A, Wickes W, White JM (2008). Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat 35: 334\u2013342.","journal-title":"J Subst Abuse Treat"},{"key":"BFnpp201524_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00213-013-3232-4","volume":"229","author":"M Mereu","year":"2013","unstructured":"Mereu M, Bonci A, Newman AH, Tanda G (2013). The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology 229: 415\u2013434.","journal-title":"Psychopharmacology"},{"key":"BFnpp201524_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/10401230490453743","volume":"16","author":"H Myrick","year":"2004","unstructured":"Myrick H, Malcolm R, Taylor B, LaRowe S (2004). Modafinil: preclinical, clinical, and post-marketing surveillance\u2014a review of abuse liability issues. Ann Clin Psychiatry 16: 101\u2013109.","journal-title":"Ann Clin Psychiatry"},{"key":"BFnpp201524_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/syn.20892","volume":"65","author":"TL Nguyen","year":"2011","unstructured":"Nguyen TL, Tian YH, You IJ, Lee SY, Jang CG. Modafinil-induced conditioned place preference via dopaminergic system in mice. Synapse, (2011) 65: 733\u2013741.","journal-title":"Synapse"},{"key":"BFnpp201524_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1037\/a0021042","volume":"18","author":"JL Newman","year":"2010","unstructured":"Newman JL, Negus SS, Lozama A, Prisinzano TE, Mello NK (2010). Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys. Exp Clin Psychopharmacol 18: 395\u2013408.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp201524_CR32","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/jm401754x","volume":"57","author":"OM Okunola-Bakare","year":"2014","unstructured":"Okunola-Bakare OM, Cao J, Kopajtic T, Katz JL, Loland CJ, Shi L et al (2014). Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues. J Med Chem 57: 1000\u20131013.","journal-title":"J Med Chem"},{"key":"BFnpp201524_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.pbb.2010.03.006","volume":"95","author":"NE Paterson","year":"2010","unstructured":"Paterson NE, Fedolak A, Olivier B, Hanania T, Ghavami A, Caldarone B (2010). Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents. Pharmacol Biochem Behav 95: 449\u2013456.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201524_CR34","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/add.12273","volume":"108","author":"KA Perkins","year":"2013","unstructured":"Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM (2013). Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction 108: 1962\u20131968.","journal-title":"Addiction"},{"key":"BFnpp201524_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00213-010-1828-5","volume":"210","author":"CM Reichel","year":"2010","unstructured":"Reichel CM, See RE (2010). Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse. Psychopharmacology 210: 337\u2013346.","journal-title":"Psychopharmacology"},{"key":"BFnpp201524_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-200342020-00002","volume":"42","author":"P Robertson Jr","year":"2003","unstructured":"Robertson P Jr, Hellriegel ET (2003). Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 42: 123\u2013137.","journal-title":"Clin Pharmacokinet"},{"key":"BFnpp201524_CR37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.biopsych.2012.12.025","volume":"73","author":"L Schmaal","year":"2013","unstructured":"Schmaal L, Goudriaan AE, Joos L, Kruse AM, Dom G, van den Brink W et al (2013). Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biol Psychiatry 73: 789\u2013795.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201524_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugalcdep.2008.04.008","volume":"98","author":"RA Schnoll","year":"2008","unstructured":"Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S et al (2008). A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend 98: 86\u201393.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201524_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","volume":"104","author":"J Shearer","year":"2009","unstructured":"Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J et al (2009). A double-blind, placebo-controlled trial of modafinil (200\u2009mg\/day) for methamphetamine dependence. Addiction 104: 224\u2013233.","journal-title":"Addiction"},{"key":"BFnpp201524_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbr.2012.07.039","volume":"235","author":"T Shuman","year":"2012","unstructured":"Shuman T, Cai DJ, Sage JR, Anagnostaras SG. Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction. Behav Brain Res, (2012) 235: 105\u2013112.","journal-title":"Behav Brain Res"},{"key":"BFnpp201524_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/hup.878","volume":"23","author":"M Sofuoglu","year":"2008","unstructured":"Sofuoglu M, Waters AJ, Mooney M (2008). Modafinil and nicotine interactions in abstinent smokers. Hum Psychopharmacol 23: 21\u201330.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp201524_CR42","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/npp.2010.94","volume":"35","author":"P Tahsili-Fahadan","year":"2010","unstructured":"Tahsili-Fahadan P, Carr GV, Harris GC, Aston-Jones G (2010). Modafinil blocks reinstatement of extinguished opiate-seeking in rats: mediation by a glutamate mechanism. Neuropsychopharmacology 35: 2203\u20132210.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201524_CR43","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jama.2009.351","volume":"301","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F et al (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301: 1148\u20131154.","journal-title":"JAMA"},{"key":"BFnpp201524_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/00912709922007534","volume":"39","author":"YN Wong","year":"1999","unstructured":"Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC et al (1999). Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol 39: 281\u2013288.","journal-title":"J Clin Pharmacol"},{"key":"BFnpp201524_CR45","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/sj.npp.1300912","volume":"31","author":"ZX Xi","year":"2006","unstructured":"Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR Jr . et al (2006b). The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 31: 1393\u20131405.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201524","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T14:25:32Z","timestamp":1747491932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnpp201524"],"URL":"https:\/\/doi.org\/10.1038\/npp.2015.24","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]},"assertion":[{"value":"9 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}